[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:renal-pelvis-cancer":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Renal Pelvis Cancer",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05756569","Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology",[11],"Phase 2","RECRUITING","2026-08-26T02:16:11.347936Z","2026-05-05T02:43:29.051565Z",[],[]]